Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Adv Skin Wound Care ; 33(8): 418-427, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32530822

ABSTRACT

OBJECTIVE: To determine if a repurposed silicone-based dressing used underneath an N95 mask is a safe and beneficial option for facial skin injury prevention without compromising the mask's seal. METHODS: Since February 21, 2020, staff in high-risk areas such as the ED and ICU of King Hamad University Hospital have worn N95 masks when performing aerosol-generating procedures to protect against the novel coronavirus 2019. At that time, without education enablers or resources that could be directly translated into practice, the hospital's Pressure Injury Prevention Committee explored, created, and tested a stepwise process to protect the skin under these masks while ensuring that it did not interfere with the effectiveness of the N95 mask seal. RESULTS: Skin protection was achieved by repurposing a readily available silicone border dressing cut into strips. This was tested on 10 volunteer staff members of various skin types and both sexes. Oxygen saturation values taken before and after the 4-hour wear test confirmed that well-fitted facial protection did not compromise the mask seal, but rather improved it. Staff also self-reported increased comfort with less friction. An educational enabler to prevent MDRPI from N95 mask wear was an important additional resource for the staff. CONCLUSIONS: This creative and novel stepwise process of developing a safe skin protection method enabling staff to apply a repurposed silicone border dressing beneath an N95 mask was largely effective and aided by the creation of the enabler.


Subject(s)
Coronavirus Infections/prevention & control , Facial Injuries/etiology , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Masks/adverse effects , Pandemics/prevention & control , Personal Protective Equipment/adverse effects , Pneumonia, Viral/prevention & control , Pressure Ulcer/prevention & control , Bandages , COVID-19 , Cohort Studies , Coronavirus Infections/epidemiology , Disease Outbreaks/statistics & numerical data , Equipment Design , Facial Injuries/physiopathology , Female , Health Personnel/statistics & numerical data , Humans , Male , Pneumonia, Viral/epidemiology , Pressure Ulcer/etiology , Prospective Studies , United States
2.
Am J Infect Control ; 40(5): 426-30, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21943830

ABSTRACT

BACKGROUND: Surgical site infections (SSIs) contribute significantly to patient morbidity and mortality and exhaust health care system resources. The main objectives of the study were to describe the incidence rates of SSIs among patients undergoing urologic or cardiothoracic surgeries, the associated risk factors, and the common causative etiologies found at Alexandria University Hospital in Egypt. METHODS: A prospective active surveillance study for patients undergoing urologic and cardiothoracic surgeries was implemented from July 2009 to December 2010. Patients were inspected daily for developing SSIs and with a 30-day postoperative follow-up. Wound swabs were obtained from patients who had clinical signs suggestive of infection. Swabs were cultured for bacterial identification and tested for antimicrobial sensitivity. Standard Centers for Disease Control and Prevention National Health Safety Network case definitions were used. RESULTS: SSIs occurred in 187 (17%) of patients with complete follow-up (n = 1,062), of which 106 (57%) occurred in-hospital and 81 (43%) occurred after discharge. Higher SSI rates were observed in cardiothoracic surgeries (23.3%), compared with urologic surgeries (9%) (P < .001). A stepwise logistic model identified an increased risk of SSI for those who underwent cardiothoracic surgeries (odds ratio [OR], 4.7; 95% confidence interval [CI], 2.2-11.1), those aged >45 years (OR, 2.32; 95% CI, 1.35-4.01), increased duration of hospital stay before (OR, 1.03; 95% CI, 1.01-1.05) and after (OR, 1.07; 95% CI, 1.04-1.09) surgery, antibiotics ≤24 hours before surgery (OR, 2.54; 95% CI, 1.63-3.94), and dirty wounds (OR, 4.09; 95% CI, 1.60-10.43). CONCLUSIONS: Measures to reduce the high rates of SSI need to be instituted through a multidisciplinary effort including infection control education and specific SSI prevention activities at Alexandria University Hospital.


Subject(s)
Surgical Wound Infection/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Bacteria/classification , Bacteria/drug effects , Bacteria/isolation & purification , Bacterial Infections/epidemiology , Bacterial Infections/microbiology , Cardiac Surgical Procedures/adverse effects , Child , Child, Preschool , Egypt/epidemiology , Female , Humans , Incidence , Infant , Male , Microbial Sensitivity Tests , Middle Aged , Prospective Studies , Risk Factors , Surgical Wound Infection/microbiology , Urologic Surgical Procedures/adverse effects , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...